Case Study

Monsanto's genetically modified organisms: The battle for hearts and shopping aisles

18 pages
August 2000
Reference: IMD-2-0086

Monsanto, an American company founded in 1901 originally specialized in chemicals. In 1995 the firm reoriented its strategy around more lucrative, but unproven, fields such as agricultural biotechnology. The case describes how in the space of a few years, Monsanto becomes market leader of bio-engineered cereal crops–commonly known as genetically modified organisms (GMOs)–but is accused of applying an unsafe gene technology and trying to dominate world food supplies. The firm is caught up in a worldwide controversy. The case documents how Monsanto was implicated in a trade dispute and reacted poorly to public criticism, particularly in its lack of dialogue with stakeholders. Overall, the case illustrates how public pressure obliged Monsanto to stop following a promising strategy.

Keywords
Environment, Agricultural Biotechnology, Pharmaceuticals, Corporate Sustainability Management
Settings
Europe, United States of America
1995-1999
Type
Published Sources
Copyright
© 2001
Available Languages
English
Related material
Teaching note
Case clearing houses
Contact

Research Information & Knowledge Hub for additional information on IMD publications

Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics